Current Assets

Restricted Cash

Alnylam Pharmaceuticals Restricted Cash decreased by 35.8% to $1.64M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 36.8%, from $2.60M to $1.64M.

Analysis

StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalContext dependent
VolatilityStable
First reportedQ3 2022
Last reportedQ4 2025

How to read this metric

An increase suggests higher regulatory or contractual obligations, potentially reducing operational liquidity, while a decrease may indicate the release of restricted funds.

Detailed definition

Cash balances that are legally or contractually restricted from being used for general corporate purposes. This often in...

Peer comparison

Standard line item for all major banks; peers disclose this to clarify the portion of cash that is not immediately available for deployment.

Metric ID: restricted_cash

Historical Data

15 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$2.30M$2.47M$2.18M$2.18M$2.16M$2.17M$2.18M$2.19M$2.84M$2.70M$2.58M$2.60M$2.18M$2.55M$1.64M
QoQ Change+7.4%-11.7%-0.0%-0.7%+0.2%+0.5%+0.5%+29.9%-4.9%-4.6%+0.7%-16.1%+17.3%-35.8%
YoY Change-5.3%-12.4%-0.6%-0.0%+1.2%+31.1%+24.1%+17.9%-8.6%-19.4%-1.0%-36.8%
Range$1.64M$2.84M
CAGR-9.2%
Avg YoY Growth-0.8%
Median YoY Growth-0.8%

Frequently Asked Questions

What is Alnylam Pharmaceuticals's restricted cash?
Alnylam Pharmaceuticals (ALNY) reported restricted cash of $1.64M in Q1 2026.
How has Alnylam Pharmaceuticals's restricted cash changed year-over-year?
Alnylam Pharmaceuticals's restricted cash decreased by 36.8% year-over-year, from $2.60M to $1.64M.
What does restricted cash mean?
Cash that is set aside for specific purposes and cannot be used for general business needs.